BioLife Solutions (BLFS) Misses Q3 EPS by 7c; Offers FY22 Revenue Guidance
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $37.07 --0%
EPS Growth %: +400.0%
Financial Fact:
Loss on disposal of property and equipment: -1.21K
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: +400.0%
Financial Fact:
Loss on disposal of property and equipment: -1.21K
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of ($0.23), $0.07 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $40.7 million versus the consensus estimate of $42.02 million.
GUIDANCE:
BioLife Solutions sees FY2022 revenue of $160-164 million, versus the consensus of $163.4 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- SailPoint Technologies Holdings (SAIL) PT Raised to $25 by Cantor Fitzgerald on Solid Checks
- ONEOK Inc (OKE) PT Raised to $95 at Scotiabank
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
